Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception

Bo Zhu, Pingjun Chen, Muhammad Aminu, Jian Rong Li, Junya Fujimoto, Yanhua Tian, Lingzhi Hong, Hong Chen, Xin Hu, Chenyang Li, Natalie Vokes, Andre L. Moreira, Don L. Gibbons, Luisa M. Solis Soto, Edwin Roger Parra Cuentas, Ou Shi, Songhui Diao, Jie Ye, Frank R. Rojas, Eduardo VilarAnirban Maitra, Ken Chen, Nicolas Navin, Monique Nilsson, Beibei Huang, Simon Heeke, Jianhua Zhang, Cara L. Haymaker, Vamsidhar Velcheti, Daniel H. Sterman, Veena Kochat, William I. Padron, Ludmil B. Alexandrov, Zhubo Wei, Xiuning Le, Linghua Wang, Junya Fukuoka, J. Jack Lee, Ignacio I. Wistuba, Harvey I. Pass, Mark Davis, Samir Hanash, Chao Cheng, Steven Dubinett, Avrum Spira, Kunal Rai, Scott M. Lippman, P. Andrew Futreal, John V. Heymach, Alexandre Reuben, Jia Wu, Jianjun Zhang*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

4 Scopus citations

Abstract

How tumor microenvironment shapes lung adenocarcinoma (LUAD) precancer evolution remains poorly understood. Spatial immune profiling of 114 human LUAD and LUAD precursors reveals a progressive increase of adaptive response and a relative decrease of innate immune response as LUAD precursors progress. The immune evasion features align the immune response patterns at various stages. TIM-3-high features are enriched in LUAD precancers, which decrease in later stages. Furthermore, single-cell RNA sequencing (scRNA-seq) and spatial immune and transcriptomics profiling of LUAD and LUAD precursor specimens from 5 mouse models validate high TIM-3 features in LUAD precancers. In vivo TIM-3 blockade at precancer stage, but not at advanced cancer stage, decreases tumor burden. Anti-TIM-3 treatment is associated with enhanced antigen presentation, T cell activation, and increased M1/M2 macrophage ratio. These results highlight the coordination of innate and adaptive immune response/evasion during LUAD precancer evolution and suggest TIM-3 as a potential target for LUAD precancer interception.

Original languageEnglish
Pages (from-to)1125-1140.e10
JournalCancer Cell
Volume43
Issue number6
DOIs
StatePublished - 09 06 2025
Externally publishedYes

Bibliographical note

Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.

Keywords

  • TIM-3
  • cancer prevention
  • imaging mass cytometry
  • immune landscape
  • lung adenocarcinoma evolution
  • precancer
  • spatial single cell
  • stage dependent
  • Humans
  • Adenocarcinoma of Lung/genetics
  • Multiomics
  • Gene Expression Profiling
  • Immunity, Innate
  • Precancerous Conditions/genetics
  • Lung Neoplasms/genetics
  • Animals
  • Tumor Microenvironment/immunology
  • Mice
  • Single-Cell Analysis
  • Hepatitis A Virus Cellular Receptor 2/genetics

Fingerprint

Dive into the research topics of 'Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception'. Together they form a unique fingerprint.

Cite this